MUSE yields 7.75% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 5
Combined, MUSE + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MUSE + MRK for your $10,000?
MUSE is actively managed to invest in a diversified portfolio of high-yield fixed income securities of any maturity. It provides exposure to various fixed income sectors, such as bank loans, foreign securities dominated in any currencies, US government and corporate bonds, and TIPS. Up to 20% can be allocated to securitized investments, such as residential and commercial mortgage-backed securities, ABS, and CLOs. It may also invest in emerging markets and distressed bonds. Portfolio selection involves independent, bottom-up research to identify securities that are undervalued and that offer a superior risk/return profile. The fund may engage in frequent trading which may increase transaction costs. It may utilize derivatives for hedging, risk management, and to increase income.
Full MUSE Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.